Galectin Therapeutics (NASDAQ:GALT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Galectin Therapeutics (GALT) operate in?

Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.

Open	$2.85
Close	$2.72
Volume / Avg.	141.32K / 135.11K
Day Range	$2.71 - $2.90
52 Wk Range	1.56 - 4.27
Market Cap	$168.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	18.12%
Days to Cover	43.25

Recent News

Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

Avi Kapoor

Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying

Avi Kapoor

Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.85
Close	$2.72
Volume / Avg.	141.32K / 135.11K
Day Range	$2.71 - $2.90
52 Wk Range	1.56 - 4.27
Market Cap	$168.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	18.12%
Days to Cover	43.25

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Galectin Therapeutics (GALT) stock?

You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.

View our list of the best stock brokerages

Who are Galectin Therapeutics (GALT) competitors?

Other companies in Galectin Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for Galectin Therapeutics (GALT) stock?

Galectin Therapeutics has a consensus price target of $11.00.

What is the current price for Galectin Therapeutics (GALT)?

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.68 last updated November 21, 2024 at 9:00 AM EST.

Does Galectin Therapeutics (GALT) pay a dividend?

There are no upcoming dividends for Galectin Therapeutics.

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

Galectin Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Galectin Therapeutics (GALT) going to split?

There is no upcoming split for Galectin Therapeutics.

What sector and industry does Galectin Therapeutics (GALT) operate in?

Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Galectin Therapeutics

Galectin Therapeutics (GALT) Forecast